https://www.mithra.com/wp-content/uploads/2019/12/Suisse-Myring.jpg 1333 2000 Mithra Pharmaceuticals https://www.mithra.com/wp-content/uploads/2017/05/logo-mithra-women-s-health.png Mithra Pharmaceuticals2019-12-05 07:30:102020-07-03 11:50:16Mithra Signs LSA for Commercialization of Myring™ in Switzerland
- Mithra grants license to Labatec for commercialization of vaginal contraceptive ring in Switzerland
- Production of Myring™ at the Mithra CDMO facility in Belgium
- Agreement follows licensing deals with major international market leaders for commercialization of Myring™
Liege, Belgium, 05 December 2019 – 7 :30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces that it has entered into a license and supply agreement with Labatec for the commercialization of its hormonal contraceptive ring Myring™ in Switzerland.